Global Jet Lag Therapy Market Worth $ 548.5 Billion by 2027 - Exclusive Report by Emergen Research ®

Коментари · 441 Виждания

The growth of the market is attributed to the increase in the number of travelers traveling to different time zones and new product launches associated with insomnia

The global Jet Lag Therapy Market will be worth USD 548.5 million by 2027, according to a current analysis by Emergen Research. Jet lag symptoms cause a wide variety of considerable health hazards to athletes, business executives and seasonal travelers, affecting a wide range of people which is around 1 billion annually. Over the years, it has been found that jet lag has very distinctive effects on the lives of travelers or those affected with this condition. There has a wide range of advancements throughout the development of recent trend setting technologies that possess properties that prevent symptoms with less effects, as compared to traditional product such as prescription drugs and melatonin.

 

The report, published by Emergen research, is a detail-oriented compilation of the crucial aspects of the Jet Lag Therapy market, including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others.

 

Market Size – USD 392.0 Million in 2019, Market Growth - CAGR of 4.3%, Market Trends –Changes in the working shift timings associated with relocation after travel.

 

To get a sample copy of the Jet Lag Therapy Market report, visit @ https://www.emergenresearch.com/request-sample/1019

The global Jet Lag Therapy market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector.  The global Jet Lag Therapy market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers acquisitions, new product launches, and joint ventures.

 

 

  • Global Europe Jet Lag Therapy market competition by TOP MANUFACTURERS, with production, price, and revenue (value) and market share for each manufacturer; the top players including:

    Key participants include Ayo (Novalogy), Lumie, Lucimed S.A., The Litebook Company Ltd., Northern Light Technologies, Nature Bright, Re-Time Pty Ltd., and Chrono Eyewear BV. among others.

 

Emergen Research has segmented the Jet Lag Therapy market on the basis of product type, application, and route of administration, distribution channel, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Prescription Drugs
  • Melatonin
  • Herbal and Natural Products
  • Medical Devices
  • Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)

  • Over the Counter
  • Online

End User Outlook (Revenue, USD Billion; 2017-2027)

  • Business Travelers
  • Cabin Crew
  • Athletes
  • Seasonal Travelers
  • Others

Regional Outlook (Revenue: USD Billion; 2017-2027)

  • North America
    1. S.
    2. Canada
    3. Mexico
  • Europe
    1. UK
    2. Germany
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

 

 

To learn more details about the Jet Lag Therapy Market report, visit @ https://www.emergenresearch.com/industry-report/martech-market

 

Key point summary of the report:

  • n July 2019, Vanda Pharmaceuticals received the FDA approval as a part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon). The drug was developed in order to treat Jet Lag Disorder especially for eastward trans-meridian travelers.
  • The medical devices segment, especially the wearable devices has been gaining traction over the years and is likely to grow at a CAGR of 3.9% over the forecast period. This can be attributed to the fact that wearable devices are versatile in nature (in terms of relevance and portability) and are majorly preferred by athletes. attributable to their advancements inside the essential style, thereby, giving a good vary of choices for numerous end-user teams. Furthermore, products like Neuroon, Re-Timer conjointly demonstrates a formidable growth and is expected to continue growing in the future, with growing awareness and emergence of jetlag therapy market across developed countries like US and Japan.

 

To get a discount on the Jet Lag Therapy  Market report, visit @ https://www.emergenresearch.com/request-discount/1019

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

 

 

 

Коментари